Amanda StiltnerAmanda Stiltner

Follow Me:

Amanda Stiltner is the associate publisher for Agora Financial/Seven Figure Publishing. She is also the editor of Seven Figure Society. Amanda’s been with Seven Figure Publishing for seven years. She has years of experience bridging the gap between retail investors and complex investment strategies.

“An Opioid ‘Kingpin’”

Reuters reported Monday: Reuters reported Monday: “Oklahoma judge to rule in $17 billion opioid lawsuit against J&J.” The actual ruling came to $572 million in fines levied against Johnson & Johnson (NYSE: JNJ). A mere drop in the bucket compared with $17 trillion investors had feared. This is what you could expect for Johnson & Johnson’s stock moving forward. Your Seven Figure Society alert inside.

Uncanny! Retails Stocks Propping up the Market?

It’s something we never thought we would utter in 2019. But Wednesday, against all odds, a few retail stocks were propping up the entire market. Here’s the one thing you need to know about picking retail winners and avoiding losers at the same time. Your Seven Figure Society alert inside...

Recession Protections: Consider Vice Stocks

Considering the extremely tough environment cannabis stocks have endured in 2019, the idea of adding a recession to the mix understandably has some investors feeling uneasy. Today we break down how a recession could impact pot stocks, as well as offer a new forecast for the rest of 2019. Your Seven Figure Society alert inside...


Word on the street yesterday was General Electric’s accounting fraud is “bigger than Enron and WorldCom combined.” That’s a serious accusation. But if the 175-page report made public yesterday turns out to be true, it could be the end for GE. Here’s our take. Your Seven Figure Society alert inside...